ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,263Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 5176

$2.71M Total Retail Price of All Prescriptions

Rank: 20 out of 5176

539 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 539 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 32,210 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

57% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

62 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
METOPROLOL SUCCINATE 1,137 1,094 1 11
NEXIUM 1,065 1,053 2 16
CRESTOR 888 845 3 15
FUROSEMIDE 809 788 4 8
AMLODIPINE BESYLATE 736 684 5 2
PLAVIX 695 690 6 29
LOVAZA 689 656 7 43
SIMVASTATIN 585 533 8 1
ZOLPIDEM TARTRATE 534 514 9 17
CREON 529 528 10 111
METOPROLOL TARTRATE 508 459 11 6
ATORVASTATIN CALCIUM 496 487 12 9
CARVEDILOL 480 454 13 24
CLOPIDOGREL 458 449 14 26
SPIRIVA 438 434 15 54
SYNTHROID 433 431 16 33
LIDODERM 414 408 17 59
OMEPRAZOLE 407 379 18 3
LIPITOR 403 398 19 51
LOSARTAN-HYDROCHLOROTHIAZIDE 387 387 20 35
TAMSULOSIN HCL 378 376 21 20
COUMADIN 376 365 22 112
POTASSIUM CHLORIDE 362 362 23 34
DIOVAN 353 353 24 19
DONEPEZIL HCL 350 350 25 28
VOLTAREN 338 328 26 97
ZETIA 328 320 27 68
METFORMIN HCL 325 287 28 7
LOSARTAN POTASSIUM 297 286 29 14
DEXILANT 284 281 30 118
ATENOLOL 276 265 31 12
DIOVAN HCT 271 267 32 39
LISINOPRIL 269 224 33 5
JANUVIA 257 257 34 25
HYDRALAZINE HCL 255 253 35 73
ADVAIR DISKUS 252 249 36 32
JANUMET 252 237 36 77
AVODART 242 242 38 107
PROCTOZONE-HC 225 225 39 171
ISOSORBIDE MONONITRATE ER 219 219 40 44
GLIMEPIRIDE 208 205 41 37
NAMENDA 190 190 42 47
ACTONEL 187 187 43 134
PRANDIN 183 176 44 150
BYSTOLIC 180 180 45 96
EXFORGE 180 170 45 126
ENALAPRIL MALEATE 179 175 47 22
MECLIZINE HCL 179 178 47 81
AZITHROMYCIN 177 168 49 42
AZOR 167 167 50 194
CELEBREX 165 163 51 80
ALCOHOL SWABS 164 162 52 115
BENICAR HCT 161 150 53 110
BENICAR 158 158 54 100
CLONIDINE HCL 155 148 55 79
RAMIPRIL 154 154 56 50
SINGULAIR 149 145 57 62
GABAPENTIN 148 137 58 21
LEXAPRO 147 140 59 193
AMMONIUM LACTATE 146 144 60 91
RANITIDINE HCL 146 137 60 36
DIGOXIN 143 143 62 56
ESCITALOPRAM OXALATE 141 133 63 89
DICYCLOMINE HCL 141 141 63 224
TRAMADOL HCL-ACETAMINOPHEN 139 134 65 116
HYDROCHLOROTHIAZIDE 139 127 65 10
TOPROL XL 138 138 67 227
LYRICA 136 130 68 133
FLUTICASONE PROPIONATE 132 130 69 38
LUNESTA 131 130 70 242
CHLORHEXIDINE GLUCONATE 126 109 71 202
VYTORIN 126 126 71 152
POLYETHYLENE GLYCOL 3350 126 124 71 74
MICARDIS HCT 124 102 74 180
IBANDRONATE SODIUM 123 123 75 211
BONIVA 121 121 76 236
ONGLYZA 112 112 77 153
AGGRENOX 112 112 77 235
DICLOFENAC SODIUM 111 111 79 160
DETROL LA 107 107 80 249
SOLARAZE 106 104 81 157
ALENDRONATE SODIUM 105 101 82 18
SERTRALINE HCL 104 101 83 30
LANSOPRAZOLE 102 100 84 113
FAMOTIDINE 100 100 85 58
NITROGLYCERIN PATCH 99 98 86 149
CLOBETASOL PROPIONATE 99 98 86 130
VESICARE 98 98 88 210
ATELVIA 96 94 89 146
MICARDIS 96 86 89 154
GLIPIZIDE 95 95 91 63
PAROXETINE HCL 93 84 92 93
AMITIZA 93 86 92 197
CYMBALTA 91 91 94 90
AMLODIPINE BESYLATE-BENAZEPRIL 90 83 95 55
PRAVASTATIN SODIUM 90 87 95 23
ASPIRIN EC 90 90 95 190
DILTIAZEM 24HR CD 89 89 98 119
LIDOCAINE 88 88 99 179
PROAIR HFA 88 84 99 60
PANTOPRAZOLE SODIUM 87 86 101 61
JALYN 86 86 102 441
CLOTRIMAZOLE-BETAMETHASONE 84 78 103 94
COLCRYS 84 81 103 170
TEKTURNA 83 83 105 255
COMBIVENT 81 81 106 156
VITAMIN D2 80 80 107 214
IBUPROFEN 80 80 107 72
EXFORGE HCT 80 68 107 266
TRICOR 80 71 107 148
SYMBICORT 79 74 111 120
EXELON 73 73 112 162
METFORMIN HCL ER 71 66 113 57
BUSPIRONE HCL 69 69 114 183
TRAMADOL HCL 68 68 115 40
CLOTRIMAZOLE 67 65 116 296
ACETAMINOPHEN-CODEINE 66 64 S3 117 127
NASONEX 66 62 117 178
LANTUS 65 52 119 66
LEVOXYL 64 60 120 238
LEVOTHYROXINE SODIUM 64 64 120 4
CILOSTAZOL 64 64 120 206
DALIRESP 62 62 123 466
MELOXICAM 60 56 124 53
NIFEDIPINE ER 59 48 125 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 53 125 49
NITROSTAT 59 58 125 205
PROPRANOLOL HCL 59 57 125 199
CIPROFLOXACIN HCL 57 52 129 84
UROXATRAL 57 57 129 599
ZOVIRAX 56 55 131 313
FLECTOR 55 54 132 282
PRAMIPEXOLE DIHYDROCHLORIDE 55 55 132 339
FOSINOPRIL SODIUM 55 42 132 105
LACTULOSE 55 53 132 87
SPIRONOLACTONE 54 54 136 88
CARTIA XT 51 51 137 406
TORSEMIDE 51 51 137 184
FINASTERIDE 50 50 139 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.